Skip to main content

Table 1 Major players in Iranian pharmaceutical market (2015)

From: The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016

Rank

Holding group

Sales value ($)

Market share (%)

Cumulative share (%)

Ownership

1

TPICO

657,753,710

17.5

0.17

Public

2

Cobel Darou

552,089,105

14.7

0.32

Private

3

Shafa Darou

293,516,423

7.8

0.40

Public

4

Behphar Holding

274,924,535

7.3

0.47

Private

5

Alborz Investment

263,503,586

7.0

0.54

Public

6

Tehran Chemie

197,998,341

5.3

0.60

Private